Atlas FDA

SYNVISC AND SYNVISC-ONE

FDA premarket approval P940015/S026 · decided 2012-06-22

Approval details

PMA number
P940015
Supplement
S026
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SYNVISC AND SYNVISC-ONE
Generic name
Acid, hyaluronic, intraarticular
Applicant
Sanofi Genzyme Corp.
Date received
2012-05-07
Decision date
2012-06-22
Days to decision
46 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Cambridge, MA
Statement
ADDITION OF A NEW WATER TREATMENT SYSTEM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.